120
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Association between anti-tuberculosis drug resistance-conferring mutations and treatment outcomes in Myanmar

ORCID Icon, , , , ORCID Icon, , & show all
Pages 388-390 | Received 15 Oct 2017, Accepted 06 Nov 2017, Published online: 01 Dec 2017
 

Acknowledgements

We thank the staff from the National TB Reference Laboratory and Yangon Regional TB Centre, Yangon, Myanmar and Massey Genome Service for technical support.

Disclosure statement

The authors declared no conflicts of interest.

Ethical approval

Ethical approval for this study was given by the Research and Ethical Committee of the University of Medicine 1, Yangon, Myanmar.

Additional information

Funding

This work was supported by the New Zealand Health Research Council (grant number 15/648).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.